MRC / BHF Heart Protection Study "HPS"

Completed

Phase N/A Results

Summary of Purpose

To assess reliably the effects on mortality and major morbidity of cholesterol-lowering therapy and of antioxidant vitamin supplementation in a wide range of different categories of high-risk patients.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 13 May 2003.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Sponsors

  • UK Medical Research Council, British Heart Foundation, Merck Sharp & Dohme, and Hoffman-LaRoche

Trial Design

Randomized 2x2 study design, with 20536 patients, including over 3000 with TIA, and nearly 7000 with minor ischemic stroke or other peripheral vascular disease.

Contacts

Not available